conference call

Ranbaxy Laboratories declared the results for the quarter ended March ’09 and held a tele conference call on 24th April’09 to discuss the financial performance as well as future plans. The key takeaways from the meet are as follows: Consolidated net sales for the quarter declined by 4% to Rs 1558.4 crore due to poor … Read more Ranbaxy Laboratories Expects revenue of Rs 7000 crore

LIC Housing Finance (LHF) held its conference call on 24th April 2009 to discuss its Q4FY09 and FY09 results. Highlights LHF reported 30% growth in Income from operations to Rs 790.48 crore. With higher rise in interest expenses, the gross profit recorded a restricted growth of 21% to Rs 218.59 crore. The Net profit for … Read more LIC Housing Finance – Expects 25% growth in disbursements in FY10

Highlights of the call The company’s sales for the quarter ended March 09 has increased by 31% to Rs 539.37 crore, supported by volume growth in Horlick by 21% and Boost by 8%. There was a overall volume growth of 20%. There was a price growth of around 7% for the quarter. A 3% excise … Read more GlaxoSmithkline Consumer Healthcare – Margin will be around 18%

Piramal Healthcare posted 9% growth in net sales to Rs 850.91 crore for the quarter ended March 2009. Operating Profit margins crashed by 650 bps to 21.0% on the back of R & D expenses of Rs 20.18 crore as against R & D income of Rs 40.48 crore in the corresponding pervious period. Resulting … Read more Piramal Healthcare – Expects a revenue growth of 16-17% for FY’10

YES bank held its conference call on 23rd April 2009 to discuss on the company’s performance for the quarter and full year ended Mar’09. Highlights Yes Bank for the quarter ended Mar’09 reported 45% growth in Net interest income at Rs 155.22 crore and 24% growth in Net profit at Rs 80.11 crore. Other income … Read more YES bank Targets 250 branches by December 2010

Highlights of the concall The company has recorded Rs 2936.49 crore consolidated revenue for Q4 FY09, 8% up Q-o-Q. The consolidated EBIDTA margins for Q4 FY09 improved 210 bps sequentially to 27.6%. At EBIDTA level, Spice and Indus have contributed Rs 69.4 crore for Q4 FY09. The consolidated PAT for the quarter stood at Rs … Read more Idea Cellular Transfer of towers to Indus results in 2.2% contraction in EBIDTA